Assignee
MORPHOSYS AG
US58 patents
Top patents by PatentIndex Score
US6300064B1Oct 9, 2001
Protein/(poly)peptide libraries
MORPHOSYS AG794 citations98
US7264963B1Sep 4, 2007
Protein(poly)peptide libraries
MORPHOSYS AG104 citations97
US6706484B1Mar 16, 2004
Protein/(poly)peptide libraries
MORPHOSYS AG158 citations97
US6696248B1Feb 24, 2004
Protein/(poly)peptide libraries
MORPHOSYS AG112 citations97
US6753136B2Jun 22, 2004
Methods for displaying (poly) peptides/proteins on bacteriophage particles via disulfide bonds
MORPHOSYS AG72 citations95
US6294353B1Sep 25, 2001
Targeted hetero-association of recombinant proteins to multi-functional complexes
MORPHOSYS AG175 citations95
US6653068B2Nov 25, 2003
Generation of specific binding partners binding to (poly)peptides encoded by genomic DNA fragments or ESTs
MORPHOSYS AG95 citations94
US9758590B2Sep 12, 2017
Anti-CD38 human antibodies and uses thereof
MORPHOSYS AG15 citations92
US6828422B1Dec 7, 2004
Protein/(poly)peptide libraries
MORPHOSYS AG95 citations91
US7867495B2Jan 11, 2011
Anti-GM-CSF antibodies and uses therefor
MORPHOSYS AG25 citations90
US9193799B2Nov 24, 2015
Fully human therapeutic antibodies specific for human CD38
MORPHOSYS AG10 citations89
US6692935B1Feb 17, 2004
Targeted hetero-association of recombinant proteins to multi-functional complexes
MORPHOSYS AG16 citations89
US6667150B1Dec 23, 2003
Method and phage for the identification of nucleic acid sequences encoding members of a multimeric (poly) peptide complex
MORPHOSYS AG23 citations88
US10184005B2Jan 22, 2019
Generation and profiling of fully human HuCAL GOLD-derived therapeutic antibodies specific for human CD38
MORPHOSYS AG4 citations83
US9289490B2Mar 22, 2016
Combinations and uses thereof
MORPHOSYS AG10 citations81
US7049135B2May 23, 2006
Method and phage for the identification of nucleic acid sequences encoding members of a multimeric (poly)peptide complex
MORPHOSYS AG15 citations79
US9486547B2Nov 8, 2016
Radiolabelled antibody and uses thereof
MORPHOSYS AG6 citations78
US10259869B2Apr 16, 2019
Antibodies for IL-17C
MORPHOSYS AG6 citations77
US11702463B2Jul 18, 2023
Canine antibody libraries
MORPHOSYS AG1 citations71
US11224654B2Jan 18, 2022
Combinations and uses thereof
MORPHOSYS AG2 citations71
US11014978B2May 25, 2021
Canine antibody libraries
MORPHOSYS AG2 citations71
US10617691B2Apr 14, 2020
Combination of an anti-CD19 antibody and a Bruton's tyrosine kinase inhibitor and uses thereof
MORPHOSYS AG3 citations71
US9541559B2Jan 10, 2017
Collection and methods for its use
MORPHOSYS AG2 citations71
US11254734B2Feb 22, 2022
Fab molecules with a rodent hinge region and a non-rodent CH1 region
MORPHOSYS AG2 citations70
US10308722B2Jun 4, 2019
Method for the treament of multiple myeloma or non-hodgkins lymphoma with anti-CD38 antibody in combination with thalidomine, lenalidomids, or pomalidomide
MORPHOSYS AG1 citations70
US9765152B2Sep 19, 2017
Method for the treatment of multiple myeloma or non-Hodgkins lymphoma with anti-CD38 antibody and bortezomib or carfilzomib
MORPHOSYS AG2 citations70
US9579378B2Feb 28, 2017
Combinations and uses thereof
MORPHOSYS AG4 citations70
US11059902B2Jul 13, 2021
Generation and profiling of fully human HuCAL GOLD-derived therapeutic antibodies specific for human CD38
MORPHOSYS AG1 citations69
US11987621B2May 21, 2024
Antibodies for IL-17C
MORPHOSYS AG1 citations66
US10633439B2Apr 28, 2020
Antibodies for IL-17C
MORPHOSYS AG2 citations66
US8367586B2Feb 5, 2013
Collection and methods for its use
MORPHOSYS AG2 citations61
US11028165B2Jun 8, 2021
Nucleic acid encoding anti-GM-CSF antibodies
MORPHOSYS AG0 citations60
US7785859B2Aug 31, 2010
Methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds
MORPHOSYS AG4 citations60
US11939395B2Mar 26, 2024
Generation and profiling of fully human HuCAL gold-derived therapeutic antibodies specific for human CD38
MORPHOSYS AG0 citations59
US11472880B2Oct 18, 2022
Humanized antibodies for CD3
MORPHOSYS AG0 citations58
US11542329B2Jan 3, 2023
Antibodies targeting Glycoprotein VI
MORPHOSYS AG1 citations57
US10919955B2Feb 16, 2021
Rodent combinatorial antibody libraries
MORPHOSYS AG0 citations57
US10774154B2Sep 15, 2020
Complex-specific antibodies and antibody fragments and its use
MORPHOSYS AG1 citations57
US12018072B2Jun 25, 2024
Antibodies specific for human complement C5A receptor (C5AR)
MORPHOSYS AG0 citations55
US11591406B2Feb 28, 2023
Treatment for multiple myeloma (MM)
MORPHOSYS AG0 citations53
US11085038B2Aug 10, 2021
Polypeptide library
MORPHOSYS AG0 citations53
US10655125B2May 19, 2020
Polypeptide library
MORPHOSYS AG1 citations53
US10533057B2Jan 14, 2020
Treatment for multiple myeloma (MM)
MORPHOSYS AG1 citations53
US11618789B2Apr 4, 2023
Clinical assessment of M-protein response in multiple myeloma
MORPHOSYS AG0 citations52
US11352620B2Jun 7, 2022
Peptide libraries
MORPHOSYS AG0 citations51
US10913792B2Feb 9, 2021
Treatment for rheumatoid arthritis
MORPHOSYS AG1 citations51
US10647757B2May 12, 2020
Collection and methods for its use
MORPHOSYS AG0 citations51
US9624293B2Apr 18, 2017
Collection and methods for its use
MORPHOSYS AG1 citations51
US10377820B2Aug 13, 2019
Methods of treatment using anti-GM-CSF antibodies
MORPHOSYS AG0 citations49
US10604566B2Mar 31, 2020
Antagonists of IL-17C for the treatment and/or prevention of atopic dermatitis
MORPHOSYS AG0 citations48
Showing the top 50 of 58 patents by PatentIndex Score.